The Respiratory Laboratory at the Guam Memorial Hospital Authority has earned recertification of its respiratory services ...

Immundiagnostik, Inc. has partnered with Epitope Diagnostics, Inc. (EDI) to offer the ECL100, a fully automated chemiluminescent immunoassay analyzer, and 50+ CLIA kits to laboratories across North ...

It was a weaker, er, week for healthcare stocks on the ASX, but takeover bids, trials and expansion deals kept the sector’s ...

Overture Life, the company behind the world's first babies born from robotic fertilization and robotic egg freezing, today ...

The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.

Lumos Diagnostics has kicked off a paediatric CLIA-waiver study in the US for its FebriDx rapid diagnostic test with the ... Read More The post Lumos starts paediatric CLIA waiver study for ...

Immune-checkpoint therapy (ICT), which attempts to harness a patient’s own immune system to fight cancer, has revolutionized cancer care over the past two decades. However, many patients do not ...

4D Medical shares gain up to 40% on FDA lung imaging device approval Lumos wins US funding for kids’ flu-versus-virus trial ‘Spend money to make money’: the lesson from the last-minute reporters In an ...

Permit approval enables expanded research capabilities and underscores commitment to accuracy, reliability, and scientific excellence The Quanterix Accelerator Laboratory is a cutting-edge facility ...

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the New York State Department of Health (NYSDOH) has granted ...